Understanding the Pathophysiology and Magnetic Resonance Imaging of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

Overview

Journal Korean J Radiol

Specialty Radiology

Date 2023 Nov 28

PMID 38016685

Authors

Laura Cacciaguerra

Maria A Rocca

Massimo Filippi

Affiliations

Soon will be listed here.

Abstract

Magnetic resonance imaging (MRI) has been extensively applied in the study of multiple sclerosis (MS), substantially contributing to diagnosis, differential diagnosis, and disease monitoring. MRI studies have significantly contributed to the understanding of MS through the characterization of typical radiological features and their clinical or prognostic implications using conventional MRI pulse sequences and further with the application of advanced imaging techniques sensitive to microstructural damage. Interpretation of results has often been validated by MRI-pathology studies. However, the application of MRI techniques in the study of neuromyelitis optica spectrum disorders (NMOSD) remains an emerging field, and MRI studies have focused on radiological correlates of NMOSD and its pathophysiology to aid in diagnosis, improve monitoring, and identify relevant prognostic factors. In this review, we discuss the main contributions of MRI to the understanding of MS and NMOSD, focusing on the most novel discoveries to clarify differences in the pathophysiology of focal inflammation initiation and perpetuation, involvement of normal-appearing tissue, potential entry routes of pathogenic elements into the CNS, and existence of primary or secondary mechanisms of neurodegeneration.

References

Havrdova E, Arnold D, Cohen J, Hartung H, Fox E, Giovannoni G . Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. Neurology. 2017; 89(11):1107-1116. PMC: 5595278. DOI: 10.1212/WNL.0000000000004313. View

Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S . Multiple sclerosis. Nat Rev Dis Primers. 2018; 4(1):43. DOI: 10.1038/s41572-018-0041-4. View

Rocca M, Longoni G, Pagani E, Boffa G, Colombo B, Rodegher M . In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis. Hum Brain Mapp. 2015; 36(11):4702-13. PMC: 6869027. DOI: 10.1002/hbm.22946. View

Chien C, Scheel M, Schmitz-Hubsch T, Borisow N, Ruprecht K, Bellmann-Strobl J . Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity. Mult Scler. 2018; 25(14):1926-1936. DOI: 10.1177/1352458518815596. View

Zivadinov R, Ramasamy D, Hagemeier J, Kolb C, Bergsland N, Schweser F . Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis. AJNR Am J Neuroradiol. 2018; 39(4):642-647. PMC: 7410777. DOI: 10.3174/ajnr.A5541. View

Naismith R, Xu J, Tutlam N, Scully P, Trinkaus K, Snyder A . Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology. 2010; 74(21):1694-701. PMC: 2882210. DOI: 10.1212/WNL.0b013e3181e042c4. View

Cramer S, Modvig S, Simonsen H, Frederiksen J, Larsson H . Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis. Brain. 2015; 138(Pt 9):2571-83. PMC: 4547053. DOI: 10.1093/brain/awv203. View

Liu Y, Duan Y, He Y, Yu C, Wang J, Huang J . A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations. Mult Scler. 2011; 18(7):1013-21. DOI: 10.1177/1352458511431731. View

Mistry N, Abdel-Fahim R, Samaraweera A, Mougin O, Tallantyre E, Tench C . Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. Mult Scler. 2015; 22(10):1289-96. DOI: 10.1177/1352458515616700. View

10.

Absinta M, Vuolo L, Rao A, Nair G, Sati P, Cortese I . Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology. 2015; 85(1):18-28. PMC: 4501940. DOI: 10.1212/WNL.0000000000001587. View

11.

Liu Z, Pardini M, Yaldizli O, Sethi V, Muhlert N, Wheeler-Kingshott C . Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis. Brain. 2015; 138(Pt 5):1239-46. PMC: 5963416. DOI: 10.1093/brain/awv065. View

12.

Lee M, Yong K, Hyun J, Kim S, Lee S, Kim H . Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder. Neurology. 2020; 95(23):e3124-e3128. DOI: 10.1212/WNL.0000000000010847. View

13.

Huh S, Min J, Kim W, Kim S, Kim H, Kim B . The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler. 2013; 20(6):695-704. DOI: 10.1177/1352458513506953. View

14.

Grussu F, Schneider T, Tur C, Yates R, Tachrount M, Ianus A . Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?. Ann Clin Transl Neurol. 2017; 4(9):663-679. PMC: 5590517. DOI: 10.1002/acn3.445. View

15.

van Waesberghe J, Kamphorst W, de Groot C, van Walderveen M, Castelijns J, Ravid R . Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999; 46(5):747-54. DOI: 10.1002/1531-8249(199911)46:5<747::aid-ana10>3.3.co;2-w. View

16.

Gaitan M, Shea C, Evangelou I, Stone R, Fenton K, Bielekova B . Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol. 2011; 70(1):22-9. PMC: 3143223. DOI: 10.1002/ana.22472. View

17.

Righart R, Biberacher V, Jonkman L, Klaver R, Schmidt P, Buck D . Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging. Ann Neurol. 2017; 82(4):519-529. PMC: 5698772. DOI: 10.1002/ana.25020. View

18.

Aboul-Enein F, Krssak M, Hoftberger R, Prayer D, Kristoferitsch W . Diffuse white matter damage is absent in neuromyelitis optica. AJNR Am J Neuroradiol. 2009; 31(1):76-9. PMC: 7964054. DOI: 10.3174/ajnr.A1791. View

19.

Jurynczyk M, Tackley G, Kong Y, Geraldes R, Matthews L, Woodhall M . Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease. J Neurol Neurosurg Psychiatry. 2016; 88(2):132-136. DOI: 10.1136/jnnp-2016-314005. View

20.

Liu Y, Xie T, He Y, Duan Y, Huang J, Ren Z . Cortical thinning correlates with cognitive change in multiple sclerosis but not in neuromyelitis optica. Eur Radiol. 2014; 24(9):2334-43. DOI: 10.1007/s00330-014-3239-1. View